<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the role of fasting hormones and pro-inflammatory cytokines in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>Hormones (ghrelin, adiponectin, and leptin) and cytokines (TNF-α, IFN-γ, and IL-6) were measured by ELISA or RIA in <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients before the administration of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy, and measurements were repeated every 2 months for 6 months </plain></SENT>
<SENT sid="2" pm="."><plain>From June 2006 to August 2008, 42 patients (19 with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and 23 with <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>) were enrolled </plain></SENT>
<SENT sid="3" pm="."><plain>In total, 21 patients were included in the <z:hpo ids='HP_0004326'>cachexia</z:hpo> group and the others served as a comparison group </plain></SENT>
<SENT sid="4" pm="."><plain>No significant difference in the initial adiponectin, ghrelin, TNF-α, IFN-γ, or IL-6 level was observed between groups, although leptin was significantly lower in cachectic patients than in the comparison group (15.3 ± 19.5 vs 80.9 ± 99.0 pg/mL, P = 0.007) </plain></SENT>
<SENT sid="5" pm="."><plain>During the follow-up, the patients who showed a &gt; 5% <z:mp ids='MP_0005456'>weight gain</z:mp> had higher ghrelin levels after 6 months </plain></SENT>
<SENT sid="6" pm="."><plain>Patients exhibiting elevated IL-6 levels typically showed a <z:hpo ids='HP_0001824'>weight loss</z:hpo> &gt; 5% after 6 months </plain></SENT>
<SENT sid="7" pm="."><plain>A blunted adiponectin or ghrelin response to <z:hpo ids='HP_0001824'>weight loss</z:hpo> may contribute to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0004326'>cachexia</z:hpo> and IL-6 may be responsible for inducing and maintaining <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0004326'>cachexia</z:hpo> </plain></SENT>
</text></document>